Efficacy of ayurvedic treatment protocol in the Management of Asrigdara (Abnormal Uterine Bleeding): An Open Labelled Single Arm Clinical Trial
Phase 3
- Conditions
- Health Condition 1: N921- Excessive and frequent menstruation with irregular cycle
- Registration Number
- CTRI/2022/02/040541
- Lead Sponsor
- institute of teaching and research in ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Both married and unmarried womens having classical features of asrigdara between age group 18-45 years.
Patient presenting with any one of the classical features will be included in study.
Exclusion Criteria
age below 18 and above 45 years, bleeding due to cervical erosion, carcinoma, fibroids and polyp, bleeding following abortion, bleeding from any site other than uterus, blood coagulation disorders,post menopausal bleeding , hb <7gm%
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is expected that the trial drug will help in normalization of menstrual cycle.Timepoint: 4Months
- Secondary Outcome Measures
Name Time Method ot applicableTimepoint: Not applicable